Asia-Pacific Smoking Cessation and Nicotine De-Addictions Market – Industry Trends and Forecast to 2030

Asia-Pacific Smoking Cessation and Nicotine De-Addictions Market, By Product Type (Nicotine Replacement Therapy Products, Drug Therapy, E-Cigarettes), Treatment Type (Pharmacological, Therapies, Others), Distribution Channel (Hospital Pharmacies, Online Provider, Drug stores and Retail Pharmacies), Forms (Gum, Inhaler, Tablet, Others), End-User (Generation Z, Millennials, Generation X, Silent Generation) - Industry Trends and Forecast to 2030.

Asia-Pacific Smoking Cessation and Nicotine De-Addictions Market Analysis and Size

Smoking addiction is a problem that is spreading quickly around the world. Teenagers and people in the labor force comprise most of this population subset. The mortality rate associated with smoking is very high. Companies are strongly encouraged to create novel smoking cessation products by the rising desire to stop smoking and the numerous health risks connected to it.

Data Bridge Market Research analyses that the smoking cessation and nicotine de-addictions market, valued at USD 18,571.05 million in 2022, will reach USD 163,044.86 million by 2030, growing at a CAGR of 31.2 % during the forecast period of 2023 to 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, and consumer behaviour.

Asia-Pacific Smoking Cessation and Nicotine De-Addictions Market Scope and Segmentation  

Market Definition

A necessary first step in overcoming nicotine addiction or stopping smoking is tobacco withdrawal. Gamma-aminobutyric acid (GABA), dopamine, and glutamate are just a few neurotransmitters nicotine, a substance found in tobacco is known to release. It is advantageous to stop smoking when treating tobacco and cigarette addiction. Quitting smoking is referred to as smoking cessation. People become dependent on cigarettes and other smoking products because of the alkaloid nicotine. The Center for Disease Control and Prevention (CDC) claims that smoking cigarettes can lead to a number of chronic diseases like lung cancer, COPD, and asthma because cigarettes contain a number of harmful chemicals.

Smoking Cessation and Nicotine De-Addictions Market Dynamics

Drivers

• Strict guidelines established by the government to manage cigarette and nicotine consumption

Given the harmful effects on the cardiovascular and respiratory systems, the government is putting a lot of emphasis on strict regulations to control nicotine and cigarette consumption. Government smoking cessation policies include smoking bans in public places, steep tobacco product taxes, and financial support for smoking cessation treatments. As a result, it is anticipated that the global market for products to help people quit smoking and wean themselves off of nicotine will expand quickly.

• An increase in the number of people attempting to stop smoking globally

The rise in the number of people trying to stop smoking is one of the key factors boosting the smoking cessation and nicotine de-addiction market's expansion. The government strongly emphasizes strict regulations to control nicotine and cigarette addiction, and high taxes on tobacco products accelerate market growth. This is due to the toxic effects of nicotine and cigarette addiction on the cardiac and respiratory systems. Furthermore, the market for nicotine addiction treatment and smoking cessation is benefited from the widespread adoption of unhealthy lifestyle choices, rapid urbanization, and rising disposable income.

Opportunities

• Growing awareness about novel nicotine replacement therapy products can create a market demand

The market for smoking cessation and nicotine de-addiction is anticipated to grow significantly due to the introduction of improved and novel nicotine replacement therapy products. Growth in the market is anticipated to be fuelled by increasing rates of target diseases such as chronic obstructive pulmonary disease (COPD), asthma, cardiac conditions, and lung cancer, as well as rising public awareness of the risks associated with smoking. To raise awareness among the young population, the educational institution continues to organize various campaigns and programs to disseminate information about the negative effects and consequences of smoking.

Restraints/Challenges

• High prices of e-cigarettes can impede the market expansion

The market has grown due to youth preference for e-cigarettes, which has increased this product's sales. However, the high price of these treatments may discourage consumers from buying them, which could ultimately restrain the market's expansion to some degree.

This smoking cessation and nicotine de-addictions market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the smoking cessation and nicotine de-addictions market, contact Data Bridge Market Research for an analyst brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2022, Takeda disclosed that it had agreed to a 15-year lease with bio-med realty for roughly 600,000 square feet of office and R&D space. Takeda, the largest life science facility in Massachusetts, would build a R&D facility with laboratories for research on contemporary design elements, upgraded technologies, and cutting-edge innovation for patients thanks to this facility. In order to maximize in-person interaction and connection under a flexible and hybrid working model, the new facility was anticipated to support Takeda's efforts to redefine the future of work.

Asia-Pacific Smoking Cessation and Nicotine De-Addictions Market Scope

The smoking cessation and nicotine de-addictions market is segmented on the basis of product type, treatment type, distribution channel, forms, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

By Product Type

• Nicotine Replacement Therapy Products
• Over-the-counter products
• Nicotine Transdermal patches
• Nicotine Lozenges
• Nicotine Gums
• Prescription Products
• Nicotine sprays
• Nicotine sublingual tablets
• Nicotine Inhalers
• Drug Therapy
• Varenicline
• Zyban (Bupropion)
• E-Cigarettes
• Modular
• Disposable
• Rechargeable

 Treatment Type

• Pharmacological
• Therapies
• Others

Distribution Channel

• Hospital Pharmacies
• Online Provider
• Drug stores and Retail Pharmacies

 Forms

• Gum
• Inhaler
• Tablet
• Others

End-User

• Generation Z
• Millennials
• Generation X
• Silent Generation

Smoking Cessation and Nicotine De-Addictions Market Regional Analysis/Insights

The smoking cessation and nicotine de-addictions market is analysed and market size insights and trends are provided by country, product type, treatment type, distribution channel, forms, and end-user as referenced above.

The countries covered in the smoking cessation and nicotine de-addictions market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)

Japan dominates the market and will continue to flourish its trend of dominance during the forecast period. The major factors that are attributable to the region's dominance are a high smoking population and increasing demand for smoking cessation and nicotine de-addiction products. The demand for pharmaceuticals and medicines is also increasing in China, India, and other countries in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Smoking Cessation and Nicotine De-Addictions Market Share Analysis

The smoking cessation and nicotine de-addictions market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to smoking cessation and nicotine de-addictions market.

Some of the major players operating in the smoking cessation and nicotine de-addictions market are:

• Imperial Brands (U.K.)
• 22nd Century Group, Inc (U.S.)
• Pfizer Inc. (U.S)
• Dr. Reddy's Laboratories Ltd (India)
• GlaxoSmithKline Plc. (U.K.)
• British American Tobacco (U.K.)
• Cambrex Corporation (U.S.)
• Cipla Inc. (U.S.)
• Fertin Pharma (Denmark)
• Johnson and Johnson private limited (U.S.)
• Perrigo Company Plc (Ireland)
• Takeda Pharmaceutical Company Limited (Japan)
• Japan Tobacco Inc. (Japan)